Viewing Study NCT05007106

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 4:03 PM
Ignite Modification Date: 2025-12-30 @ 5:29 AM
Study NCT ID: NCT05007106
Status: COMPLETED
Last Update Posted: 2025-08-14
First Post: 2021-08-10
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)
Sponsor: Merck Sharp & Dohme LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Uterine Cervical Neoplasms View
None Endometrial Neoplasms View
None Squamous Cell Carcinoma of Head and Neck View
None Gallbladder Neoplasms View
None Cholangiocarcinoma View
None Esophageal Neoplasms View
None Triple Negative Breast Neoplasms View
None Hepatocellular Carcinoma View
None Urinary Bladder Neoplasms View
None Ovarian Neoplasms View
None Stomach Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Programmed Cell Death-1 (PD1, PD-1) View
None Programmed Death-Ligand 1 (PDL1, PD-L1) View